$LRCXBullishMed

What Do Analysts Say About Lam Research (LRCX)’s Earnings Outlook?

As of June 1, 2026, 29 of 36 analysts rate Lam Research (LRCX) bullish, with a street-high price target of $385 and implied upside of 21%. Mizuho upgraded May 27 to “Outperform” and raised its target to $380, lifting 2026 wafer fab equipment spending to $153B and 2027 to $190B. Morgan Stanley upgraded May 18 to “Overweight” with a $331 target; B. Riley reiterated “Buy,” raising its target to $385.

8/10
5/10
Med
Bullish
after-hours / pre-next analyst cycle (June 1 sentiment snapshot; upgrades dated May 12/18/27)
bullish—multiple firms reiterate/upgrade with higher street-high targets

Street expectations are being ratcheted higher for LRCX via upgraded capex assumptions and tighter DRAM/NAND equipment demand revisions.

Analyst firms raised Lam Research’s 2026–2027 wafer-fab equipment spending outlook and price targets, citing stronger NAND/DRAM capex read-through.

Near-term bias to the upside as upgrades/target hikes reinforce momentum, but magnitude likely capped unless upcoming prints confirm the capex rerating.

Background

The article compiles Wall Street/analyst commentary on Lam Research’s earnings outlook, focusing on wafer-fab equipment spending rerating and specific broker target changes.

Why it matters

Upgrades and higher 2026–2027 capex estimates for the wafer-fab equipment space are presented as the key driver for improved earnings expectations for LRCX.

Market relevance

Multiple broker actions (upgrades + higher targets) reinforce a bullish consensus around LRCX tied to AI-related semiconductor capex and NAND/DRAM transition dynamics.

Market effects

Supports the broader wafer-fab equipment/AI infrastructure demand narrative, reinforcing positive read-through for equipment demand expectations.

No specific regional catalyst cited; impact primarily via global semiconductor capex expectations.

Global NAND/DRAM transition and TSMC spending assumptions underpin the equipment demand thesis.

Alternative perspectives

Analyst target hikes may already be priced; if NAND/DRAM pricing or hyperscaler capex slows, the equipment rerating could unwind quickly.

The piece emphasizes spending estimates and revisions but does not quantify execution risk, order timing, or margin sensitivity to equipment demand volatility.

Key entities

  • Lam Research Corporation

    Semiconductor manufacturing equipment and services supplier; subject of the analyst outlook and target revisions.

  • Mizuho

    Raised LRCX price target to $380 and increased 2026/2027 wafer-fab equipment spending estimates.

  • Morgan Stanley

    Upgraded LRCX to Overweight with a higher price target, citing narrowed DRAM revisions and constructive NAND outlook.

  • B. Riley

    Raised LRCX price target to $385, citing faster-than-expected AI-driven capex.

Related articles

$LRCXMedAI 8/10

Mizuho Raises its Price Target on Lam Research (LRCX)

Mizuho raised its Lam Research (LRCX) price target to $380 from $330 and kept an Outperform rating, citing higher 2026 wafer fab equipment spending estimates ($153B vs $142B) and 2027 ($190B vs $163B). It said current earnings estimates are underestimated due to NAND transitions, TSMC spending, and stronger DRAM/HBM pricing. Morgan Stanley upgraded LRCX to Overweight with a $331 target, while B. Riley raised its target to $385.

$LRCXLow

Lam Research Corp (LRCX): Increasing Dependence on Essential Chip Manufacturing

Green Alpha Investment’s Q1 2026 investor letter highlights Lam Research (LRCX), citing its role as a supplier of etch and deposition tools for AI-related chip manufacturing. The firm says HBM-related tool revenue grew over 50% year over year and Lam’s cryogenic etch won a 2025 SEMI award. It reports LRCX March-quarter 2026 revenue of $5.84B (+9% sequential, +24% YoY) and notes 123 hedge funds held the stock at end of Q1.

$AMATMedAI 8/10

Stock Indexes Post New Record Highs Amid AI Enthusiasm

US stock indexes hit new record highs as investors weighed AI optimism and a low implied chance of Fed tightening, with markets pricing a 2% probability of a +25 bp hike at the June 16-17 FOMC. Bloomberg Intelligence said 84% of S&P 500 Q1 reporters beat estimates; Q1 earnings seen +12% y/y. Rates, Europe CPI, and sector movers were mixed.

$ONMedAI 8/10

Stocks Push Higher on US Labor Market Strength and AI Spending

US stocks rose as investors weighed strong labor-market data and ongoing AI spending, despite hawkish remarks from Cleveland Fed President Beth Hammack that the policy rate “may not be restrictive” and could need tightening if inflation stays elevated. Markets priced only a ~1% chance of a +25 bp Fed hike at June 16-17. Q1: 84% of 485 S&P 500 firms beat estimates; earnings seen +12% y/y.

$TMMed

Japanese Market Sharply Lower

Japan’s Nikkei 225 fell sharply on Thursday, down 1,118.16 points (1.63%) to 67,283.97, after a low of 67,262.86, reversing Wednesday’s gains and reflecting broadly negative Wall Street cues. Weakness led by exporters and index heavyweights; SoftBank Group fell over 8%, Panasonic nearly 5%, Sony over 2%. The dollar traded around 159 yen.

$MRVLMedAI 9/10

AI Frenzy And Strong Jobs Data Drive S&P 500 (SPY), Dow (DJIA), And Nasdaq (QQQ) To All-Time Highs

S&P 500 (SPY) rose 0.13% to a record close, the Dow (DIA) gained 0.45%, and Nasdaq 100 (QQQ) added 0.48%, after early losses. The move was attributed to AI spending enthusiasm, strong Q1 earnings (84% of 485 S&P 500 firms beat estimates, per the report) and higher US April JOLTS job openings (7.618M). Marvell jumped 32% on Nvidia CEO Huang’s $1T comment; HPE surged 19% on an above-estimate sales outlook.